首页> 外国专利> A method for isolating a T cell receptor that has antigen specificity for cancer-specific mutations

A method for isolating a T cell receptor that has antigen specificity for cancer-specific mutations

机译:分离对癌症特异性突变具有抗原特异性的T细胞受体的方法

摘要

PROBLEM TO BE SOLVED: To provide a method for isolating a T cell receptor having antigen specificity for a cancer-specific mutation. A method of isolating a TCR having antigen specificity for a mutated amino acid sequence encoded by a cancer-specific mutation, wherein each gene encodes a mutated amino acid sequence. Identifying one or more genes in the nucleic acid of a patient's cancer cells that contain a mutated mutation; inducing the patient's auto-APC to present a mutated amino acid sequence; Co-culturing with an autologous APC that presents a mutated amino acid sequence; selecting an autologous T cell; and isolating a nucleotide sequence encoding the TCR from the selected autologous T cell, TCR A method having antigen specificity for a mutated amino acid sequence encoded by a cancer-specific mutation. [Selection diagram] None
机译:解决的问题:提供一种分离对癌症特异性突变具有抗原特异性的T细胞受体的方法。一种分离对由癌症特异性突变编码的突变氨基酸序列具有抗原特异性的TCR的方法,其中每个基因编码一个突变的氨基酸序列。鉴定患者癌细胞核酸中包含突变的一个或多个基因;诱导患者的自身APC呈现突变的氨基酸序列;与呈现突变的氨基酸序列的自体APC共培养;选择自体T细胞; TCR一种从选定的自体T细胞中分离出编码TCR的核苷酸序列的方法,该方法对由癌症特异性突变编码的突变氨基酸序列具有抗原特异性。 [选择图]无

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号